Chase Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chase Investment Counsel's LLY Position: Q2 2026 in Review
Chase Investment Counsel increased its Eli Lilly (LLY) stake by 441% in Q2 2026, buying an estimated $1.38M and bringing the position to 1,660 shares worth $1.99M. The position accounts for 0.42% of the portfolio, ranked #48.
Chase Investment Counsel first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chase Investment Counsel held 1,660 shares of Eli Lilly worth $1.99M as of Q2 2026.
- Chase Investment Counsel bought 1,353 Eli Lilly shares in Q2 2026, an estimated $1.38M.
- Eli Lilly made up 0.42% of Chase Investment Counsel's portfolio in Q2 2026, its #48 holding.
- Chase Investment Counsel first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.